GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

[News]

Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.

More... (http://www.news-medical.net/news/20110318/GHDX-presents-Oncotype-DX-breast-cancer-test-study-results-at-St-Gallen-conference.aspx)